Exploiting immunogenic cell death to promote antitumor immunity
Trends in Immunology · 2026
DOI: 10.1016/j.it.2026.03.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026. Verfasst von Gabriele Casagrande Raffi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Immunogenic Cell Death. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Health~Holland, Mark Foundation For Cancer Research.
Abstract (Originalsprache)
Immunogenic cell death (ICD) converts the death of a tumor cell into an event sensed by the immune system. Recent studies show that distinct ICD modalities, including immunogenic apoptosis, pyroptosis, necroptosis, and hybrid forms such as PANoptosis, release defined sets of danger signals and cytokines that reshape the immune composition of the tumor microenvironment. In this review, we examine how ICD activates antitumor immunity and which immune cell subsets drive these responses. We also discuss how the benefits of ICD rely on its acute and transient nature, whereas prolonged or chronic exposure to the same inflammatory cues can ultimately dampen immune activation and promote oncogenesis. Finally, we outline the role of ICD and its clinical relevance in combination with immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.
- Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospita…
- State Key Laboratory of Oncology in South China, Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. Electronic address: wanglq1@sysucc.org.cn.
- Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands. Electronic address: r.bernards@nki.nl.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Health~Holland
- Mark Foundation For Cancer Research
- Key Technologies Research and Development Program
- National Health Commission of the People's Republic of China
- National Key Research and Development Program of China
- Sun Yat-sen University Cancer Center
- Ministerie van Volksgezondheid, Welzijn en Sport
Zitieren
APA
Casagrande Raffi, G., Wang, S., Wang, L., & Bernards, R. (2026). Exploiting immunogenic cell death to promote antitumor immunity. Trends in Immunology. https://doi.org/10.1016/j.it.2026.03.006
Vancouver
Casagrande Raffi G, Wang S, Wang L, Bernards R. Exploiting immunogenic cell death to promote antitumor immunity. Trends in Immunology. 2026. doi:10.1016/j.it.2026.03.006
BibTeX
@article{CasagrandeRaffi2026,
author = {Casagrande Raffi, Gabriele and Wang, Siying and Wang, Liqin and Bernards, Rene},
title = {Exploiting immunogenic cell death to promote antitumor immunity},
journal = {Trends in Immunology},
year = {2026},
doi = {10.1016/j.it.2026.03.006}
}
EUVIMED